Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Contingent Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹800 Cr₹1,063 Cr₹337 Cr₹361 Cr₹384 Cr

What is the latest Contingent Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Contingent Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹800 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹800 Cr
Mar2024₹1,063 Cr
Mar2023₹337 Cr
Mar2022₹361 Cr
Mar2021₹384 Cr

How is Contingent Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Contingent Liabilities % Change
Mar2025 ₹800 Cr
-24.74
Mar2024 ₹1,063 Cr
215.81
Mar2023 ₹337 Cr
-6.81
Mar2022 ₹361 Cr
-5.96
Mar2021 ₹384 Cr -

Compare Contingent Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,599.6 Cr -2.4% 7% 54.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,825.0 Cr -1.7% 4% 11.8% Stock Analytics
DIVIS LABORATORIES ₹161,535.0 Cr -4.7% -1.8% 10.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,733.0 Cr -3.7% 4.5% 42.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,094.0 Cr -3% 0% 15.4% Stock Analytics
CIPLA ₹103,513.0 Cr -2.6% -2.3% -10.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2.4%

7%

54.8%

SENSEX

-2.7%

-9.1%

2.6%


You may also like the below Video Courses